Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æÀÇ È­»ý¼º ÆíÆò»óÇǼ¼Æ÷¾ÏÁ¾ 17¿¹¿¡ ´ëÇÑ ÀÓ»ó ¹× º´¸®ÇÐÀû ºÐ¼® Metaplastic Squamous Carcinoma of the Breast: Clinicopathologic Analysis of 17 Cases

´ëÇѺ´¸®ÇÐȸÁö 2009³â 43±Ç 1È£ p.20 ~ 25
À̼±¾Æ, ÀÌ°æÀº, ¹®º´ÀÎ, ÇÑ¿î¼·, ¼º¼øÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
À̼±¾Æ ( Lee Sun-Ah ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

ÀÌ°æÀº ( Lee Kyong-Eun ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¹®º´ÀΠ( Moon Byung-In ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÇÑ¿î¼· ( Han Woon-Sub ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼º¼øÈñ ( Sung Sun-Hee ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background: Squamous cell carcinoma of the breast is very rare and it is considered to arise from metaplastic change of ductal carcinoma. Metaplastic squamous cell carcinoma (MSC) of the breast includes pure squamous cell carcinoma, metaplastic adenosquamous carcinoma and low grade adenosquamous carcinoma. Most of the cases of MSC of the breast were reported to have lymph node metastasis and this has a worse prognosis than that of conventional
invasive ductal carcinoma.

Methods: We collected 17 cases of MSC of the breast from 1,173 cases of breast cancer and analyzed the clinicopathological characteristics.

Results: The age range was 31 to 69 years (mean age: 47.2). The mean tumor size was 3.6 cm. Twelve cases (70.6%) had a negative nodal status. The majority of the cases were of a high nuclear grade (grade III: 76.5%), and a high histologic grade (grade III: 88.2%). All the cases had no amplification of HER2, and they were negative for hormonal receptors, except for 2 cases withn weak positivity. All the cases showed positivity for EGFR (3+: 14 cases, 1+: 3 cases). Clinical relapse was found in 3 patients on follow up and two of them expired due to lung and bone metastasis.
Conclusions: MSC is associated with high nuclear and histologic grades, a high EGFR expression and they are triple negative for ER, PR, and HER2. The EGFR immunopositivity of MSC suggests a basal-like subtype.

Å°¿öµå

Breast cancer;Squamous cell carcinoma;Epidermal growth factor receptor;TP63 protein;human

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS